Fosun Pharma is a key unit within mainland conglomerate Fosun International’s health division: Photo: Handout Fosun Pharma is a key unit within mainland conglomerate Fosun International’s health division: Photo: Handout
Fosun Pharma is a key unit within mainland conglomerate Fosun International’s health division: Photo: Handout
Pharmaceuticals

BioNTech vaccine agent, Fosun Pharma, seeks more global sales through M&A opportunities, push into new markets

  • Company aims to raise offshore sales to 40 per cent of group revenue over five years, from about 27 per cent in 2020
  • Company intends to launch three to four biosimilars and innovative drugs this year, and more in 2022 as additional candidates pass through R&D phase

Topic |   Pharmaceuticals
Fosun Pharma is a key unit within mainland conglomerate Fosun International’s health division: Photo: Handout Fosun Pharma is a key unit within mainland conglomerate Fosun International’s health division: Photo: Handout
Fosun Pharma is a key unit within mainland conglomerate Fosun International’s health division: Photo: Handout
READ FULL ARTICLE